01 2Alcon Canada Inc.
02 2Gowling WLG (Canada) LLP
01 22080223
02 12310230
03 12763778
01 1BRIMONIDINE TARTRATE | BRINZOLAMIDE
02 1Brinzolamide
03 2Brinzolamide | Timolol Maleate
01 1SUSPENSION
02 1Suspension
03 2suspension
01 22011-04-03
02 12018-11-05
03 12030-06-17
Patent Expiration Date : 2011-04-03
Date Granted : 2000-11-07
Brand Name : AZARGA
Patent Number : 2080223
Filing Date : 1991-04-03
Strength per Unit : 1% / 0.5%
Dosage Form : suspension
Human Or VET : Human
Route of Administration : ophthalmic (topical)
Patent Expiration Date : 2011-04-03
Date Granted : 2000-11-07
Patent Expiration Date : 2018-11-05
Date Granted : 2008-05-06
Brand Name : AZARGA
Patent Number : 2310230
Filing Date : 1998-11-05
Strength per Unit : 1% / 0.5%
Dosage Form : suspension
Human Or VET : Human
Route of Administration : ophthalmic (topical)
Patent Expiration Date : 2018-11-05
Date Granted : 2008-05-06
Patent Expiration Date : 2011-04-03
Date Granted : 2000-11-07
Brand Name : AZOPT
Patent Number : 2080223
Filing Date : 1991-04-03
Strength per Unit : 10mg/ml
Dosage Form : Suspension
Human Or VET : Human
Route of Administration : Topical (Ophthalmic)
Patent Expiration Date : 2011-04-03
Date Granted : 2000-11-07
Patent Expiration Date : 2030-06-17
Date Granted : 2016-02-02
BRIMONIDINE TARTRATE, BRINZOLAMIDE
Brand Name : SIMBRINZA
Patent Number : 2763778
Filing Date : 2010-06-17
Strength per Unit : 1.0% / 0.2% w / v
Dosage Form : SUSPENSION
Human Or VET : Human
Route of Administration : OPHTHALMIC
Patent Expiration Date : 2030-06-17
Date Granted : 2016-02-02
